Viemed Healthcare Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Casey Hoyt
Chief executive officer
US$2.5m
Total compensation
| CEO salary percentage | 20.3% |
| CEO tenure | 7yrs |
| CEO ownership | 5.6% |
| Management average tenure | 7yrs |
| Board average tenure | 7yrs |
Recent management updates
Recent updates
When Should You Buy Viemed Healthcare, Inc. (NASDAQ:VMD)?
Apr 11
These 4 Measures Indicate That Viemed Healthcare (NASDAQ:VMD) Is Using Debt Safely
Mar 07Viemed Healthcare: Comments On Q2 Earnings
Aug 25Viemed Healthcare Q2 2022 Earnings Preview
Aug 02Viemed Healthcare: New Bullish Trend Has Just Begun
Dec 29Viemed Healthcare, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 06Viemed Healthcare EPS misses by $0.01, revenue in-line
May 03Strong Execution By Insider-Owners Ensures Viemed's Growth
Jan 11Viemed Healthcare EPS misses by $0.02, beats on revenue
Nov 05CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$10m |
| Jun 30 2024 | n/a | n/a | US$9m |
| Mar 31 2024 | n/a | n/a | US$10m |
| Dec 31 2023 | US$3m | US$509k | US$10m |
| Sep 30 2023 | n/a | n/a | US$9m |
| Jun 30 2023 | n/a | n/a | US$7m |
| Mar 31 2023 | n/a | n/a | US$6m |
| Dec 31 2022 | US$2m | US$470k | US$6m |
| Sep 30 2022 | n/a | n/a | US$8m |
| Jun 30 2022 | n/a | n/a | US$9m |
| Mar 31 2022 | n/a | n/a | US$9m |
| Dec 31 2021 | US$2m | US$470k | US$9m |
| Sep 30 2021 | n/a | n/a | US$10m |
| Jun 30 2021 | n/a | n/a | US$11m |
| Mar 31 2021 | n/a | n/a | US$29m |
| Dec 31 2020 | US$2m | US$441k | US$32m |
| Sep 30 2020 | n/a | n/a | US$29m |
| Jun 30 2020 | n/a | n/a | US$29m |
| Mar 31 2020 | n/a | n/a | US$11m |
| Dec 31 2019 | US$2m | US$425k | US$9m |
| Sep 30 2019 | n/a | n/a | US$9m |
| Jun 30 2019 | n/a | n/a | US$8m |
| Mar 31 2019 | n/a | n/a | US$9m |
| Dec 31 2018 | US$2m | US$389k | US$10m |
| Sep 30 2018 | n/a | n/a | US$7m |
| Jun 30 2018 | n/a | n/a | US$9m |
| Mar 31 2018 | n/a | n/a | US$8m |
| Dec 31 2017 | US$1m | US$235k | US$8m |
Compensation vs Market: Casey's total compensation ($USD2.51M) is about average for companies of similar size in the US market ($USD2.22M).
Compensation vs Earnings: Casey's compensation has increased by more than 20% in the past year.
CEO
Casey Hoyt (47 yo)
7yrs
Tenure
US$2,512,214
Compensation
Mr. Casey Hoyt has been Director of Viemed Healthcare, Inc. since December 14, 2016 and Chief Executive Officer since December 2017. Mr. Hoyt served as Chief Executive Officer of Patient Home Monitoring Co...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 7yrs | US$2.51m | 5.58% $ 17.3m | |
| President | 7yrs | US$1.95m | 4.75% $ 14.8m | |
| Chief Financial Officer | 7yrs | US$826.39k | 0.17% $ 530.1k | |
| COO & Director | 7yrs | US$1.94m | 0.57% $ 1.8m | |
| Vice President of Sales | 6.8yrs | US$805.30k | 0.19% $ 594.2k | |
| Chief Medical Officer & Director | 7yrs | US$328.08k | 0.17% $ 541.1k | |
| EVP, Chief Legal Officer & Corporate Secretary | 2.3yrs | no data | 0.028% $ 88.5k | |
| Chief Business Development Officer | 2.3yrs | no data | no data |
7.0yrs
Average Tenure
49yo
Average Age
Experienced Management: VMD's management team is seasoned and experienced (7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 8yrs | US$2.51m | 5.58% $ 17.3m | |
| COO & Director | 7yrs | US$1.94m | 0.57% $ 1.8m | |
| Chief Medical Officer & Director | 7yrs | US$328.08k | 0.17% $ 541.1k | |
| Independent Chairman | 7yrs | US$221.63k | 0.28% $ 859.5k | |
| Independent Director | 7yrs | US$202.00k | 0.33% $ 1.0m | |
| Independent Director | 4.1yrs | US$191.00k | 0.13% $ 413.0k | |
| Independent Director | 7yrs | US$204.00k | 0.24% $ 731.4k | |
| Independent Director | 6.4yrs | US$199.63k | 0.20% $ 611.7k |
7.0yrs
Average Tenure
59yo
Average Age
Experienced Board: VMD's board of directors are considered experienced (7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:52 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Viemed Healthcare, Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nick Corcoran | Acumen Capital Finance Partners Limited |
| Doug Cooper | Beacon Securities Limited |
| Vadim Merkulov | Freedom Broker |